

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium ion export (GO:0071436) | 9.12270226 |
| 2 | retinal rod cell development (GO:0046548) | 8.17377354 |
| 3 | protein neddylation (GO:0045116) | 7.92945872 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 7.88101966 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 7.49331887 |
| 6 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 7.41956866 |
| 7 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 6.86115872 |
| 8 | response to pheromone (GO:0019236) | 6.67478210 |
| 9 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 6.31099893 |
| 10 | retinal cone cell development (GO:0046549) | 6.30829325 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 6.27705868 |
| 12 | regulation of platelet aggregation (GO:0090330) | 6.10849793 |
| 13 | potassium ion homeostasis (GO:0055075) | 6.10016642 |
| 14 | synaptic vesicle exocytosis (GO:0016079) | 6.01862737 |
| 15 | cellular sodium ion homeostasis (GO:0006883) | 5.94506508 |
| 16 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.85368304 |
| 17 | blood coagulation, intrinsic pathway (GO:0007597) | 5.83694230 |
| 18 | regulation of platelet activation (GO:0010543) | 5.82535025 |
| 19 | cell communication by electrical coupling (GO:0010644) | 5.81402620 |
| 20 | adenosine receptor signaling pathway (GO:0001973) | 5.54852676 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.50505419 |
| 22 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 5.40167823 |
| 23 | response to host (GO:0075136) | 5.40167823 |
| 24 | response to host defenses (GO:0052200) | 5.40167823 |
| 25 | platelet aggregation (GO:0070527) | 5.37279987 |
| 26 | response to host immune response (GO:0052572) | 5.26230276 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.26230276 |
| 28 | synaptic vesicle endocytosis (GO:0048488) | 5.24436103 |
| 29 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.21269918 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 5.11934731 |
| 31 | negative regulation of norepinephrine secretion (GO:0010700) | 5.07309153 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 5.04912490 |
| 33 | negative regulation of platelet activation (GO:0010544) | 4.95840850 |
| 34 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.94844528 |
| 35 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.86773685 |
| 36 | innervation (GO:0060384) | 4.85992482 |
| 37 | positive regulation of mast cell activation (GO:0033005) | 4.84243866 |
| 38 | calcium ion import (GO:0070509) | 4.77655009 |
| 39 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.76975864 |
| 40 | negative regulation of heart rate (GO:0010459) | 4.72624673 |
| 41 | lipoxygenase pathway (GO:0019372) | 4.67659960 |
| 42 | angiogenesis involved in wound healing (GO:0060055) | 4.67129359 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.64561565 |
| 44 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.55110936 |
| 45 | neutrophil activation (GO:0042119) | 4.54012221 |
| 46 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.44838585 |
| 47 | mating behavior (GO:0007617) | 4.43049111 |
| 48 | low-density lipoprotein particle remodeling (GO:0034374) | 4.41486549 |
| 49 | nitric oxide mediated signal transduction (GO:0007263) | 4.40451665 |
| 50 | eye photoreceptor cell development (GO:0042462) | 4.38353480 |
| 51 | cGMP biosynthetic process (GO:0006182) | 4.35221768 |
| 52 | relaxation of muscle (GO:0090075) | 4.33862018 |
| 53 | photoreceptor cell development (GO:0042461) | 4.29990412 |
| 54 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.22100664 |
| 55 | platelet degranulation (GO:0002576) | 4.19100392 |
| 56 | regulation of lipoprotein metabolic process (GO:0050746) | 4.17172334 |
| 57 | membrane depolarization during action potential (GO:0086010) | 4.14407109 |
| 58 | protein localization to synapse (GO:0035418) | 4.08119617 |
| 59 | regulation of synapse maturation (GO:0090128) | 4.03170193 |
| 60 | negative regulation of protein localization to cell surface (GO:2000009) | 4.03015155 |
| 61 | potassium ion export (GO:0071435) | 3.99656177 |
| 62 | granulocyte activation (GO:0036230) | 3.98677997 |
| 63 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.94587524 |
| 64 | regulation of integrin activation (GO:0033623) | 3.93186775 |
| 65 | iron coordination entity transport (GO:1901678) | 3.91510241 |
| 66 | synaptic vesicle transport (GO:0048489) | 3.89328680 |
| 67 | establishment of synaptic vesicle localization (GO:0097480) | 3.89328680 |
| 68 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.88430906 |
| 69 | megakaryocyte development (GO:0035855) | 3.87100593 |
| 70 | negative regulation of appetite (GO:0032099) | 3.84953110 |
| 71 | negative regulation of response to food (GO:0032096) | 3.84953110 |
| 72 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.84707664 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.83103152 |
| 74 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.82944911 |
| 75 | atrial cardiac muscle cell action potential (GO:0086014) | 3.82066690 |
| 76 | platelet activation (GO:0030168) | 3.81715005 |
| 77 | positive regulation of macrophage differentiation (GO:0045651) | 3.79960118 |
| 78 | homotypic cell-cell adhesion (GO:0034109) | 3.78903475 |
| 79 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.75323047 |
| 80 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.73625054 |
| 81 | platelet formation (GO:0030220) | 3.73125801 |
| 82 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.70412155 |
| 83 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.69733594 |
| 84 | beta-amyloid metabolic process (GO:0050435) | 3.69557600 |
| 85 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.68856073 |
| 86 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.67755344 |
| 87 | positive regulation of receptor recycling (GO:0001921) | 3.67609392 |
| 88 | apical protein localization (GO:0045176) | 3.65247315 |
| 89 | polyamine biosynthetic process (GO:0006596) | 3.63305598 |
| 90 | purinergic receptor signaling pathway (GO:0035587) | 3.62357541 |
| 91 | protein-chromophore linkage (GO:0018298) | 3.60432004 |
| 92 | synaptic vesicle maturation (GO:0016188) | 3.59745232 |
| 93 | striatum development (GO:0021756) | 3.58465587 |
| 94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.57699113 |
| 95 | glycolytic process (GO:0006096) | 3.56156548 |
| 96 | sodium ion homeostasis (GO:0055078) | 3.55945775 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 3.53125660 |
| 98 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.53117399 |
| 99 | positive regulation of hemostasis (GO:1900048) | 3.52920412 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 3.52920412 |
| 101 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.50346298 |
| 102 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.50232738 |
| 103 | sialylation (GO:0097503) | 3.49336715 |
| 104 | negative regulation of heart contraction (GO:0045822) | 3.48752337 |
| 105 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.47918932 |
| 106 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.47384094 |
| 107 | cGMP metabolic process (GO:0046068) | 3.47184793 |
| 108 | negative regulation of smooth muscle contraction (GO:0045986) | 3.46525291 |
| 109 | regulation of cGMP biosynthetic process (GO:0030826) | 3.44082787 |
| 110 | regulation of norepinephrine secretion (GO:0014061) | 3.43561050 |
| 111 | extracellular fibril organization (GO:0043206) | 3.40510860 |
| 112 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.39689951 |
| 113 | negative regulation of T cell apoptotic process (GO:0070233) | 3.36602658 |
| 114 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.35383803 |
| 115 | glutamate receptor signaling pathway (GO:0007215) | 3.34800999 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.33415299 |
| 117 | positive regulation of gastrulation (GO:2000543) | 3.32864846 |
| 118 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.32011099 |
| 119 | membrane hyperpolarization (GO:0060081) | 3.31276014 |
| 120 | termination of signal transduction (GO:0023021) | 3.29120117 |
| 121 | regulation of endothelial cell differentiation (GO:0045601) | 3.27496273 |
| 122 | positive regulation of cGMP metabolic process (GO:0030825) | 3.20807795 |
| 123 | neuroblast proliferation (GO:0007405) | 3.19919928 |
| 124 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.17971484 |
| 125 | positive regulation of coagulation (GO:0050820) | 3.16900073 |
| 126 | mitochondrial calcium ion transport (GO:0006851) | 3.15973354 |
| 127 | visual perception (GO:0007601) | 3.14328135 |
| 128 | autophagic vacuole fusion (GO:0000046) | 3.14237417 |
| 129 | high-density lipoprotein particle remodeling (GO:0034375) | 3.14124467 |
| 130 | response to caffeine (GO:0031000) | 3.13367523 |
| 131 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.13329467 |
| 132 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.13286851 |
| 133 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.13286851 |
| 134 | sensory perception of light stimulus (GO:0050953) | 3.13233451 |
| 135 | leukocyte degranulation (GO:0043299) | 3.12207935 |
| 136 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.12123099 |
| 137 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.12123099 |
| 138 | negative regulation of catecholamine secretion (GO:0033604) | 3.11637523 |
| 139 | regulation of mast cell activation (GO:0033003) | 3.11504845 |
| 140 | prepulse inhibition (GO:0060134) | 3.11312472 |
| 141 | phospholipid homeostasis (GO:0055091) | 3.11104613 |
| 142 | anterograde axon cargo transport (GO:0008089) | 3.09636119 |
| 143 | potassium ion transmembrane transport (GO:0071805) | 3.08536742 |
| 144 | cellular potassium ion transport (GO:0071804) | 3.08536742 |
| 145 | urinary tract smooth muscle contraction (GO:0014848) | 3.07402108 |
| 146 | regulation of cGMP metabolic process (GO:0030823) | 3.04924782 |
| 147 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.04081694 |
| 148 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.03917332 |
| 149 | regulation of cholesterol efflux (GO:0010874) | 3.03470557 |
| 150 | axon cargo transport (GO:0008088) | 3.02788338 |
| 151 | reverse cholesterol transport (GO:0043691) | 3.02760498 |
| 152 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.02257301 |
| 153 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.02257301 |
| 154 | phagocytosis, engulfment (GO:0006911) | 3.01717846 |
| 155 | synapse assembly (GO:0007416) | 3.01677616 |
| 156 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.96915481 |
| 157 | positive regulation of mast cell degranulation (GO:0043306) | 2.96915481 |
| 158 | photoreceptor cell maintenance (GO:0045494) | 2.96780399 |
| 159 | regulation of female receptivity (GO:0045924) | 2.96240928 |
| 160 | regulation of blood coagulation (GO:0030193) | 2.95406221 |
| 161 | regulation of hemostasis (GO:1900046) | 2.95406221 |
| 162 | negative regulation of stress fiber assembly (GO:0051497) | 2.94553492 |
| 163 | regulation of receptor recycling (GO:0001919) | 2.93032335 |
| 164 | potassium ion import (GO:0010107) | 2.92719495 |
| 165 | glucocorticoid biosynthetic process (GO:0006704) | 2.92255709 |
| 166 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.92156215 |
| 167 | vesicle targeting (GO:0006903) | 2.92090067 |
| 168 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.91966031 |
| 169 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91521701 |
| 170 | positive regulation of calcium ion import (GO:0090280) | 2.90583724 |
| 171 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.90042655 |
| 172 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.89608844 |
| 173 | fibril organization (GO:0097435) | 2.88406305 |
| 174 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.87015108 |
| 175 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.86883509 |
| 176 | regulation of synaptic vesicle transport (GO:1902803) | 2.86436772 |
| 177 | positive regulation of granulocyte differentiation (GO:0030854) | 2.86191806 |
| 178 | regulation of neurotransmitter secretion (GO:0046928) | 2.85928304 |
| 179 | regulation of regulatory T cell differentiation (GO:0045589) | 2.85691836 |
| 180 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.85676571 |
| 181 | regulation of mast cell degranulation (GO:0043304) | 2.85223845 |
| 182 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.84460962 |
| 183 | rhodopsin mediated signaling pathway (GO:0016056) | 2.84201835 |
| 184 | relaxation of cardiac muscle (GO:0055119) | 2.83730911 |
| 185 | retinal ganglion cell axon guidance (GO:0031290) | 2.83398648 |
| 186 | vocalization behavior (GO:0071625) | 2.82558813 |
| 187 | regulation of memory T cell differentiation (GO:0043380) | 2.81207697 |
| 188 | retina development in camera-type eye (GO:0060041) | 2.80308926 |
| 189 | neurotransmitter secretion (GO:0007269) | 2.80059588 |
| 190 | cyclooxygenase pathway (GO:0019371) | 2.79908523 |
| 191 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.79229930 |
| 192 | neurotransmitter transport (GO:0006836) | 2.78988284 |
| 193 | peristalsis (GO:0030432) | 2.78942341 |
| 194 | plasma membrane fusion (GO:0045026) | 2.77505850 |
| 195 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75139076 |
| 196 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.70345093 |
| 197 | relaxation of smooth muscle (GO:0044557) | 11.5817628 |
| 198 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 11.4864228 |
| 199 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.4529886 |
| 200 | detection of light stimulus involved in visual perception (GO:0050908) | 11.4529886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.76848117 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.28786141 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.11700615 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.04873703 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72587533 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35281339 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.28688399 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.26658071 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.24813250 |
| 10 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.11638800 |
| 11 | GATA1_19941826_ChIP-Seq_K562_Human | 2.95957666 |
| 12 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.83072502 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78754954 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.77517493 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69525872 |
| 16 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 2.69195109 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.62394785 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57401883 |
| 19 | GATA2_19941826_ChIP-Seq_K562_Human | 2.56931551 |
| 20 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.55853328 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52744912 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48677472 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44676907 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.39995553 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39765350 |
| 26 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.39257636 |
| 27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.38764963 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38301578 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36300945 |
| 30 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.35129935 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34425370 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28603145 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.28303287 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.27548951 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.26500069 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.22121391 |
| 37 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.19721558 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.14991797 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14668941 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14597257 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.14205170 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.10967980 |
| 43 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.09422619 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.08653039 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03415125 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 2.00243954 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.96562343 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.94609407 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.93414054 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88639410 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.88476250 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.88476250 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.87623291 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.87617369 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85708602 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85036929 |
| 57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84215968 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84043720 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83963400 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82535821 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79731327 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.79115218 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77773938 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75162612 |
| 65 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75081125 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73020005 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72999948 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72225912 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.67172348 |
| 70 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.66991001 |
| 71 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.66196989 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63144389 |
| 73 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60422362 |
| 74 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.59912311 |
| 75 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59220450 |
| 76 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.56063797 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53304720 |
| 78 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.50163539 |
| 79 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49183979 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48017712 |
| 81 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47535957 |
| 82 | AR_19668381_ChIP-Seq_PC3_Human | 1.47132345 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.45118024 |
| 84 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.41196868 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39429387 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38617206 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38275051 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36799150 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34833643 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.32082802 |
| 91 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31293780 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29888368 |
| 93 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29316035 |
| 94 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28136827 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26907013 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26907013 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26749601 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.26677267 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.25717800 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.24715990 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.23933380 |
| 102 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.23680381 |
| 103 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23444615 |
| 104 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.23083156 |
| 105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22982023 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22097038 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21799119 |
| 108 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18585486 |
| 109 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18482145 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18482145 |
| 111 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17474367 |
| 112 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17442315 |
| 113 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.16735353 |
| 114 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16420596 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.16112002 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.15931884 |
| 117 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.14263434 |
| 118 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12833381 |
| 119 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11966593 |
| 120 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11200203 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10065708 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.09837358 |
| 123 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09080541 |
| 124 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.07996817 |
| 125 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.07792693 |
| 126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07252797 |
| 127 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06501227 |
| 128 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.06433244 |
| 129 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06078585 |
| 130 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.06010445 |
| 131 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05893046 |
| 132 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04450168 |
| 133 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04032293 |
| 134 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.02351317 |
| 135 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01775459 |
| 136 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.01283413 |
| 137 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01024609 |
| 138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00635802 |
| 139 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99665810 |
| 140 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99379315 |
| 141 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99309287 |
| 142 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.98314192 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.97820438 |
| 144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.97094609 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96395680 |
| 146 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.96248455 |
| 147 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95864393 |
| 148 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95636461 |
| 149 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95568040 |
| 150 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95429060 |
| 151 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.93982703 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93841083 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93354347 |
| 154 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93168096 |
| 155 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92960876 |
| 156 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92670947 |
| 157 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92637722 |
| 158 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91905616 |
| 159 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89073061 |
| 160 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88714255 |
| 161 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87663603 |
| 162 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87404075 |
| 163 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.87140845 |
| 164 | MYB_26560356_Chip-Seq_TH2_Human | 0.85564905 |
| 165 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84017124 |
| 166 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83894005 |
| 167 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.83191824 |
| 168 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82925491 |
| 169 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80489535 |
| 170 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79977082 |
| 171 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78975943 |
| 172 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78787323 |
| 173 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78385035 |
| 174 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78375363 |
| 175 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77627028 |
| 176 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77441936 |
| 177 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.76700473 |
| 178 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76290248 |
| 179 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76189479 |
| 180 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76184424 |
| 181 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75557095 |
| 182 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74503747 |
| 183 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.74193860 |
| 184 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74078576 |
| 185 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.73797017 |
| 186 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73664949 |
| 187 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.73355881 |
| 188 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72986458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 6.73207605 |
| 2 | MP0002090_abnormal_vision | 5.42584808 |
| 3 | MP0008004_abnormal_stomach_pH | 5.30039674 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 5.04875919 |
| 5 | MP0001984_abnormal_olfaction | 4.13481970 |
| 6 | MP0001502_abnormal_circadian_rhythm | 4.11028802 |
| 7 | MP0004782_abnormal_surfactant_physiolog | 4.10312768 |
| 8 | MP0003724_increased_susceptibility_to | 4.06638177 |
| 9 | MP0004233_abnormal_muscle_weight | 3.69127839 |
| 10 | MP0000465_gastrointestinal_hemorrhage | 3.53777025 |
| 11 | MP0005253_abnormal_eye_physiology | 3.36994411 |
| 12 | MP0008775_abnormal_heart_ventricle | 3.22451706 |
| 13 | MP0004510_myositis | 3.04357004 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.84960271 |
| 15 | MP0001346_abnormal_lacrimal_gland | 2.73642540 |
| 16 | MP0005195_abnormal_posterior_eye | 2.67798537 |
| 17 | MP0002638_abnormal_pupillary_reflex | 2.65754199 |
| 18 | MP0005248_abnormal_Harderian_gland | 2.61031489 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.59229011 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.48362124 |
| 21 | MP0003303_peritoneal_inflammation | 2.44571535 |
| 22 | MP0000343_altered_response_to | 2.38457465 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.24173011 |
| 24 | MP0005670_abnormal_white_adipose | 2.20472543 |
| 25 | MP0003950_abnormal_plasma_membrane | 2.14138176 |
| 26 | MP0005083_abnormal_biliary_tract | 2.06029798 |
| 27 | MP0005464_abnormal_platelet_physiology | 10.0193683 |
| 28 | MP0005595_abnormal_vascular_smooth | 1.95155365 |
| 29 | MP0003828_pulmonary_edema | 1.94792411 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.92797901 |
| 31 | MP0005671_abnormal_response_to | 1.90527695 |
| 32 | MP0004215_abnormal_myocardial_fiber | 1.87487863 |
| 33 | MP0002332_abnormal_exercise_endurance | 1.87153837 |
| 34 | MP0003638_abnormal_response/metabolism_ | 1.80207288 |
| 35 | MP0001486_abnormal_startle_reflex | 1.78698369 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.77042646 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.76473529 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.76115739 |
| 39 | MP0001879_abnormal_lymphatic_vessel | 1.74136915 |
| 40 | MP0000631_abnormal_neuroendocrine_gland | 1.73916182 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.73564643 |
| 42 | MP0005084_abnormal_gallbladder_morpholo | 1.73359674 |
| 43 | MP0003880_abnormal_central_pattern | 1.70044240 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.65431854 |
| 45 | MP0003635_abnormal_synaptic_transmissio | 1.61684738 |
| 46 | MP0005000_abnormal_immune_tolerance | 1.61259074 |
| 47 | MP0005410_abnormal_fertilization | 1.61207989 |
| 48 | MP0001324_abnormal_eye_pigmentation | 1.60385272 |
| 49 | MP0004130_abnormal_muscle_cell | 1.58126407 |
| 50 | MP0008872_abnormal_physiological_respon | 1.55976992 |
| 51 | MP0002064_seizures | 1.55963375 |
| 52 | MP0002272_abnormal_nervous_system | 1.55119846 |
| 53 | MP0002752_abnormal_somatic_nervous | 1.54038053 |
| 54 | MP0001851_eye_inflammation | 1.53213108 |
| 55 | MP0002229_neurodegeneration | 1.50984287 |
| 56 | MP0001188_hyperpigmentation | 1.50552094 |
| 57 | MP0002398_abnormal_bone_marrow | 1.46814901 |
| 58 | MP0003436_decreased_susceptibility_to | 1.46335324 |
| 59 | MP0005391_vision/eye_phenotype | 1.43946660 |
| 60 | MP0002184_abnormal_innervation | 1.41369620 |
| 61 | MP0004947_skin_inflammation | 1.40574287 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.39411688 |
| 63 | MP0000249_abnormal_blood_vessel | 1.37483406 |
| 64 | MP0005646_abnormal_pituitary_gland | 1.36193733 |
| 65 | MP0003011_delayed_dark_adaptation | 1.35707481 |
| 66 | MP0002063_abnormal_learning/memory/cond | 1.35409784 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.34550804 |
| 68 | MP0005499_abnormal_olfactory_system | 1.34550804 |
| 69 | MP0002132_abnormal_respiratory_system | 1.32375809 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.31669461 |
| 71 | MP0009046_muscle_twitch | 1.31663650 |
| 72 | MP0001663_abnormal_digestive_system | 1.31203436 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.30102579 |
| 74 | MP0002723_abnormal_immune_serum | 1.28479612 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.28142796 |
| 76 | MP0001545_abnormal_hematopoietic_system | 1.27643243 |
| 77 | MP0005397_hematopoietic_system_phenotyp | 1.27643243 |
| 78 | MP0010368_abnormal_lymphatic_system | 1.27126939 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.25752396 |
| 80 | MP0009763_increased_sensitivity_to | 1.24680046 |
| 81 | MP0001800_abnormal_humoral_immune | 1.22967717 |
| 82 | MP0003137_abnormal_impulse_conducting | 1.21859212 |
| 83 | MP0002733_abnormal_thermal_nociception | 1.20186415 |
| 84 | MP0000858_altered_metastatic_potential | 1.19970158 |
| 85 | MP0008789_abnormal_olfactory_epithelium | 1.17767912 |
| 86 | MP0009697_abnormal_copulation | 1.17420463 |
| 87 | MP0002452_abnormal_antigen_presenting | 1.15862213 |
| 88 | MP0010329_abnormal_lipoprotein_level | 1.15528692 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 1.15501265 |
| 90 | MP0009764_decreased_sensitivity_to | 1.15452348 |
| 91 | MP0009745_abnormal_behavioral_response | 1.15322925 |
| 92 | MP0002882_abnormal_neuron_morphology | 1.14115506 |
| 93 | MP0008260_abnormal_autophagy | 1.13240663 |
| 94 | MP0003866_abnormal_defecation | 1.12114574 |
| 95 | MP0001968_abnormal_touch/_nociception | 1.09936898 |
| 96 | MP0004859_abnormal_synaptic_plasticity | 1.09096350 |
| 97 | MP0005423_abnormal_somatic_nervous | 1.06681296 |
| 98 | MP0000689_abnormal_spleen_morphology | 1.06353004 |
| 99 | MP0002429_abnormal_blood_cell | 1.04634937 |
| 100 | MP0002420_abnormal_adaptive_immunity | 1.04552280 |
| 101 | MP0001819_abnormal_immune_cell | 1.03344737 |
| 102 | MP0002089_abnormal_postnatal_growth/wei | 1.03310354 |
| 103 | MP0008874_decreased_physiological_sensi | 1.02262306 |
| 104 | MP0002419_abnormal_innate_immunity | 1.00293944 |
| 105 | MP0008569_lethality_at_weaning | 0.98913910 |
| 106 | MP0002572_abnormal_emotion/affect_behav | 0.97082785 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.95645093 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.95585434 |
| 109 | MP0001790_abnormal_immune_system | 0.94328281 |
| 110 | MP0005387_immune_system_phenotype | 0.94328281 |
| 111 | MP0002722_abnormal_immune_system | 0.94146923 |
| 112 | MP0000566_synostosis | 0.94095665 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.93340649 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93169368 |
| 115 | MP0000685_abnormal_immune_system | 0.92907575 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.92539024 |
| 117 | MP0009642_abnormal_blood_homeostasis | 0.92461944 |
| 118 | MP0000716_abnormal_immune_system | 0.91342252 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.90328285 |
| 120 | MP0005025_abnormal_response_to | 0.89870782 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.88948918 |
| 122 | MP0003634_abnormal_glial_cell | 0.87846168 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.87029866 |
| 124 | MP0005620_abnormal_muscle_contractility | 0.86811930 |
| 125 | MP0005165_increased_susceptibility_to | 0.86019147 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.85959774 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.85582378 |
| 128 | MP0005409_darkened_coat_color | 0.85393699 |
| 129 | MP0004142_abnormal_muscle_tone | 0.84379901 |
| 130 | MP0006054_spinal_hemorrhage | 0.84227052 |
| 131 | MP0009780_abnormal_chondrocyte_physiolo | 0.83804890 |
| 132 | MP0001765_abnormal_ion_homeostasis | 0.83396390 |
| 133 | MP0004484_altered_response_of | 0.82860736 |
| 134 | MP0004085_abnormal_heartbeat | 0.81871695 |
| 135 | MP0005023_abnormal_wound_healing | 0.81810174 |
| 136 | MP0000955_abnormal_spinal_cord | 0.81693824 |
| 137 | MP0002653_abnormal_ependyma_morphology | 0.80955490 |
| 138 | MP0005381_digestive/alimentary_phenotyp | 0.80492232 |
| 139 | MP0009333_abnormal_splenocyte_physiolog | 0.80160516 |
| 140 | MP0003890_abnormal_embryonic-extraembry | 0.79949775 |
| 141 | MP0002972_abnormal_cardiac_muscle | 0.79938720 |
| 142 | MP0005385_cardiovascular_system_phenoty | 0.79136027 |
| 143 | MP0001544_abnormal_cardiovascular_syste | 0.79136027 |
| 144 | MP0006138_congestive_heart_failure | 0.77512969 |
| 145 | MP0002736_abnormal_nociception_after | 0.76077029 |
| 146 | MP0000534_abnormal_ureter_morphology | 0.75295481 |
| 147 | MP0003959_abnormal_lean_body | 0.75047713 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.74777277 |
| 149 | MP0003136_yellow_coat_color | 0.74253301 |
| 150 | MP0003075_altered_response_to | 0.73217151 |
| 151 | MP0002557_abnormal_social/conspecific_i | 0.72209047 |
| 152 | MP0001664_abnormal_digestion | 0.72145792 |
| 153 | MP0002069_abnormal_eating/drinking_beha | 0.71667442 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.70651500 |
| 155 | MP0006276_abnormal_autonomic_nervous | 0.70513470 |
| 156 | MP0005174_abnormal_tail_pigmentation | 0.70026235 |
| 157 | MP0000751_myopathy | 0.68878817 |
| 158 | MP0002128_abnormal_blood_circulation | 0.68179996 |
| 159 | MP0005535_abnormal_body_temperature | 0.68040608 |
| 160 | MP0004883_abnormal_blood_vessel | 0.67843417 |
| 161 | MP0005666_abnormal_adipose_tissue | 0.66667414 |
| 162 | MP0000003_abnormal_adipose_tissue | 0.65097163 |
| 163 | MP0005501_abnormal_skin_physiology | 0.63439087 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.63198754 |
| 165 | MP0003633_abnormal_nervous_system | 0.62854491 |
| 166 | MP0000703_abnormal_thymus_morphology | 0.62685916 |
| 167 | MP0002152_abnormal_brain_morphology | 0.62019379 |
| 168 | MP0003879_abnormal_hair_cell | 0.61932817 |
| 169 | MP0009672_abnormal_birth_weight | 0.61488640 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.60722838 |
| 171 | MP0001727_abnormal_embryo_implantation | 0.60672586 |
| 172 | MP0005266_abnormal_metabolism | 0.59929993 |
| 173 | MP0002066_abnormal_motor_capabilities/c | 0.58861858 |
| 174 | MP0002108_abnormal_muscle_morphology | 0.56018739 |
| 175 | MP0004811_abnormal_neuron_physiology | 0.55360376 |
| 176 | MP0004924_abnormal_behavior | 0.54710784 |
| 177 | MP0005386_behavior/neurological_phenoty | 0.54710784 |
| 178 | MP0001970_abnormal_pain_threshold | 0.54639142 |
| 179 | MP0004742_abnormal_vestibular_system | 0.52502637 |
| 180 | MP0002127_abnormal_cardiovascular_syste | 0.52348080 |
| 181 | MP0003172_abnormal_lysosome_physiology | 0.52198022 |
| 182 | MP0005220_abnormal_exocrine_pancreas | 0.51699912 |
| 183 | MP0003698_abnormal_male_reproductive | 0.51073131 |
| 184 | MP0000778_abnormal_nervous_system | 0.50733306 |
| 185 | MP0002751_abnormal_autonomic_nervous | 0.48319281 |
| 186 | MP0002269_muscular_atrophy | 0.43993325 |
| 187 | MP0002697_abnormal_eye_size | 0.43751023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.93099457 |
| 2 | Purpura (HP:0000979) | 9.22433324 |
| 3 | Central scotoma (HP:0000603) | 8.22929580 |
| 4 | Epistaxis (HP:0000421) | 7.89174283 |
| 5 | Septo-optic dysplasia (HP:0100842) | 7.29601844 |
| 6 | Severe visual impairment (HP:0001141) | 7.28269974 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.18062345 |
| 8 | Gingival bleeding (HP:0000225) | 6.80152575 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 6.26056167 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.80410740 |
| 11 | Impaired platelet aggregation (HP:0003540) | 5.72557151 |
| 12 | Abnormal platelet function (HP:0011869) | 5.72557151 |
| 13 | Scotoma (HP:0000575) | 5.44514237 |
| 14 | Epileptic encephalopathy (HP:0200134) | 5.04351185 |
| 15 | Decreased central vision (HP:0007663) | 5.03207120 |
| 16 | Albinism (HP:0001022) | 4.98442447 |
| 17 | Febrile seizures (HP:0002373) | 4.89136135 |
| 18 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.74397936 |
| 19 | Hypoplasia of the fovea (HP:0007750) | 4.74397936 |
| 20 | Abnormal pupillary function (HP:0007686) | 4.68742804 |
| 21 | Spontaneous hematomas (HP:0007420) | 4.39947714 |
| 22 | Hemiparesis (HP:0001269) | 4.30983343 |
| 23 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.13415216 |
| 24 | Poikilocytosis (HP:0004447) | 4.12464637 |
| 25 | Acanthocytosis (HP:0001927) | 4.05967062 |
| 26 | Abnormal gallbladder physiology (HP:0012438) | 4.04884899 |
| 27 | Cholecystitis (HP:0001082) | 4.04884899 |
| 28 | Abnormality of the fovea (HP:0000493) | 3.84789541 |
| 29 | Conjunctival telangiectasia (HP:0000524) | 3.83665465 |
| 30 | Absent septum pellucidum (HP:0001331) | 3.74284899 |
| 31 | Optic nerve hypoplasia (HP:0000609) | 3.54795383 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.52692167 |
| 33 | Bruising susceptibility (HP:0000978) | 3.47729957 |
| 34 | Absence seizures (HP:0002121) | 3.46093185 |
| 35 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.35237473 |
| 36 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 3.17686219 |
| 37 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.15540063 |
| 38 | Paralysis (HP:0003470) | 3.10142511 |
| 39 | Abnormality of the septum pellucidum (HP:0007375) | 3.07790359 |
| 40 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.02355004 |
| 41 | Keratoconus (HP:0000563) | 3.00962678 |
| 42 | Increased corneal curvature (HP:0100692) | 3.00962678 |
| 43 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.97799653 |
| 44 | Abnormality of lateral ventricle (HP:0030047) | 2.97778386 |
| 45 | Severe Myopia (HP:0011003) | 2.91946075 |
| 46 | Increased density of long bones (HP:0006392) | 2.91566275 |
| 47 | Prolonged QT interval (HP:0001657) | 2.91391193 |
| 48 | Abnormality of the sella turcica (HP:0002679) | 2.90564479 |
| 49 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.80809435 |
| 50 | Dialeptic seizures (HP:0011146) | 2.75183210 |
| 51 | Generalized hypopigmentation (HP:0007513) | 2.74171444 |
| 52 | Attenuation of retinal blood vessels (HP:0007843) | 2.71817822 |
| 53 | Progressive cerebellar ataxia (HP:0002073) | 2.64864026 |
| 54 | Growth hormone deficiency (HP:0000824) | 2.64580751 |
| 55 | Primary adrenal insufficiency (HP:0008207) | 2.63718024 |
| 56 | Stomatitis (HP:0010280) | 2.63041314 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.60655363 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.60217357 |
| 59 | Joint swelling (HP:0001386) | 2.55294840 |
| 60 | Xanthomatosis (HP:0000991) | 2.53137605 |
| 61 | Abnormal auditory evoked potentials (HP:0006958) | 2.48638715 |
| 62 | Congenital sensorineural hearing impairment (HP:0008527) | 2.46430907 |
| 63 | Pendular nystagmus (HP:0012043) | 2.45743797 |
| 64 | Increased IgM level (HP:0003496) | 2.44868437 |
| 65 | Mutism (HP:0002300) | 2.38919653 |
| 66 | Joint hemorrhage (HP:0005261) | 2.38765527 |
| 67 | Visual hallucinations (HP:0002367) | 2.35649462 |
| 68 | Abdominal situs inversus (HP:0003363) | 2.35592167 |
| 69 | Abnormality of abdominal situs (HP:0011620) | 2.35592167 |
| 70 | Dysdiadochokinesis (HP:0002075) | 2.33896106 |
| 71 | Upper limb muscle weakness (HP:0003484) | 2.33703471 |
| 72 | Gastrointestinal dysmotility (HP:0002579) | 2.32241285 |
| 73 | Tinnitus (HP:0000360) | 2.28752210 |
| 74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26371263 |
| 75 | Chorioretinal coloboma (HP:0000567) | 2.25514373 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.20511164 |
| 77 | Photophobia (HP:0000613) | 2.18458061 |
| 78 | Male infertility (HP:0003251) | 2.11352222 |
| 79 | Spontaneous abortion (HP:0005268) | 2.10816861 |
| 80 | Generalized aminoaciduria (HP:0002909) | 2.09574110 |
| 81 | Papillary thyroid carcinoma (HP:0002895) | 2.07412431 |
| 82 | Cone-rod dystrophy (HP:0000548) | 2.04786572 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03060936 |
| 84 | Fatigue (HP:0012378) | 2.01040505 |
| 85 | Nausea (HP:0002018) | 2.00795748 |
| 86 | Dysautonomia (HP:0002459) | 2.00635462 |
| 87 | Encephalitis (HP:0002383) | 2.00330517 |
| 88 | Congenital stationary night blindness (HP:0007642) | 16.9702604 |
| 89 | Prolonged bleeding time (HP:0003010) | 11.9703464 |
| 90 | Menorrhagia (HP:0000132) | 11.0467706 |
| 91 | Increased mean platelet volume (HP:0011877) | 10.8320160 |
| 92 | Abnormal platelet volume (HP:0011876) | 10.2384220 |
| 93 | Thyroid-stimulating hormone excess (HP:0002925) | 1.99538562 |
| 94 | Abolished electroretinogram (ERG) (HP:0000550) | 1.99183194 |
| 95 | Episodic fever (HP:0001954) | 1.95586623 |
| 96 | Arterial thrombosis (HP:0004420) | 1.94354634 |
| 97 | Scanning speech (HP:0002168) | 1.92569098 |
| 98 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92275791 |
| 99 | Gait imbalance (HP:0002141) | 1.91480122 |
| 100 | Chronic obstructive pulmonary disease (HP:0006510) | 1.89619314 |
| 101 | Obstructive lung disease (HP:0006536) | 1.89619314 |
| 102 | Genetic anticipation (HP:0003743) | 1.89064171 |
| 103 | Ventricular fibrillation (HP:0001663) | 1.86845980 |
| 104 | Abnormality of the lower motor neuron (HP:0002366) | 1.86622453 |
| 105 | Eczematoid dermatitis (HP:0000976) | 1.85011939 |
| 106 | Erectile abnormalities (HP:0100639) | 1.84286678 |
| 107 | Depression (HP:0000716) | 1.83981010 |
| 108 | Unsteady gait (HP:0002317) | 1.83726208 |
| 109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83375476 |
| 110 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83213825 |
| 111 | Hyperthyroidism (HP:0000836) | 1.82355762 |
| 112 | Congenital primary aphakia (HP:0007707) | 1.82251989 |
| 113 | Myocardial infarction (HP:0001658) | 1.82206790 |
| 114 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80442899 |
| 115 | Type II diabetes mellitus (HP:0005978) | 1.80302862 |
| 116 | Increased serum ferritin (HP:0003281) | 1.80007947 |
| 117 | Myoglobinuria (HP:0002913) | 1.78957286 |
| 118 | Abnormal EKG (HP:0003115) | 1.78873370 |
| 119 | Flat cornea (HP:0007720) | 1.78572522 |
| 120 | Scrotal hypoplasia (HP:0000046) | 1.78128448 |
| 121 | Neoplasm of the heart (HP:0100544) | 1.77525490 |
| 122 | Polycythemia (HP:0001901) | 1.77089929 |
| 123 | Abnormality of the parathyroid morphology (HP:0011766) | 1.76765347 |
| 124 | Exercise-induced muscle cramps (HP:0003710) | 1.76713211 |
| 125 | Epileptiform EEG discharges (HP:0011182) | 1.76427971 |
| 126 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75458364 |
| 127 | Retinitis pigmentosa (HP:0000510) | 1.74493749 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.72843799 |
| 129 | Abnormal ciliary motility (HP:0012262) | 1.72109614 |
| 130 | True hermaphroditism (HP:0010459) | 1.70376088 |
| 131 | Vertigo (HP:0002321) | 1.70092776 |
| 132 | Arthropathy (HP:0003040) | 1.69933168 |
| 133 | Biliary tract neoplasm (HP:0100574) | 1.67120133 |
| 134 | Basal ganglia calcification (HP:0002135) | 1.66171448 |
| 135 | Atrial fibrillation (HP:0005110) | 1.64512131 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.64129164 |
| 137 | Uterine leiomyosarcoma (HP:0002891) | 1.63995146 |
| 138 | Leiomyosarcoma (HP:0100243) | 1.63995146 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.63477429 |
| 140 | Poor coordination (HP:0002370) | 1.63088769 |
| 141 | Medial flaring of the eyebrow (HP:0010747) | 1.62998336 |
| 142 | Autoimmune hemolytic anemia (HP:0001890) | 1.62060565 |
| 143 | Tongue fasciculations (HP:0001308) | 1.61950990 |
| 144 | Action tremor (HP:0002345) | 1.61194394 |
| 145 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.61096827 |
| 146 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.59317043 |
| 147 | Cutis marmorata (HP:0000965) | 1.57981851 |
| 148 | Dyschromatopsia (HP:0007641) | 1.56955849 |
| 149 | Muscle fibrillation (HP:0010546) | 1.56876094 |
| 150 | Hemiplegia (HP:0002301) | 1.56708954 |
| 151 | Increased cerebral lipofuscin (HP:0011813) | 1.56277179 |
| 152 | Abnormality of binocular vision (HP:0011514) | 1.56224034 |
| 153 | Diplopia (HP:0000651) | 1.56224034 |
| 154 | Chorioretinal atrophy (HP:0000533) | 1.56106407 |
| 155 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.55489833 |
| 156 | Chest pain (HP:0100749) | 1.55062882 |
| 157 | Exercise-induced myalgia (HP:0003738) | 1.54632854 |
| 158 | Long toe (HP:0010511) | 1.54044638 |
| 159 | Neoplasm of the oral cavity (HP:0100649) | 1.53540477 |
| 160 | Pigmentary retinal degeneration (HP:0001146) | 1.51654946 |
| 161 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.51333440 |
| 162 | Testicular neoplasm (HP:0010788) | 1.50241781 |
| 163 | Polyphagia (HP:0002591) | 1.49815750 |
| 164 | Thrombocytosis (HP:0001894) | 1.49346796 |
| 165 | Generalized tonic-clonic seizures (HP:0002069) | 1.49244819 |
| 166 | Dysostosis multiplex (HP:0000943) | 1.48343972 |
| 167 | Hand muscle atrophy (HP:0009130) | 1.48018047 |
| 168 | Primary atrial arrhythmia (HP:0001692) | 1.47763673 |
| 169 | Infertility (HP:0000789) | 1.46827998 |
| 170 | Supranuclear gaze palsy (HP:0000605) | 1.44824151 |
| 171 | Mucosal telangiectasiae (HP:0100579) | 1.44745748 |
| 172 | Drooling (HP:0002307) | 1.44338879 |
| 173 | Excessive salivation (HP:0003781) | 1.44338879 |
| 174 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.43277485 |
| 175 | Bladder carcinoma (HP:0002862) | 1.43260256 |
| 176 | Bladder neoplasm (HP:0009725) | 1.43260256 |
| 177 | Thyroid carcinoma (HP:0002890) | 1.42958652 |
| 178 | Astigmatism (HP:0000483) | 1.41749300 |
| 179 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.41654935 |
| 180 | X-linked recessive inheritance (HP:0001419) | 1.40936965 |
| 181 | Thrombophlebitis (HP:0004418) | 1.40435435 |
| 182 | Supraventricular tachycardia (HP:0004755) | 1.40150748 |
| 183 | Choroideremia (HP:0001139) | 1.39076287 |
| 184 | Mitral stenosis (HP:0001718) | 1.37764551 |
| 185 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.35755260 |
| 186 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.35755260 |
| 187 | Leukocytosis (HP:0001974) | 1.35652491 |
| 188 | Abnormality of alanine metabolism (HP:0010916) | 1.35492027 |
| 189 | Hyperalaninemia (HP:0003348) | 1.35492027 |
| 190 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.35492027 |
| 191 | Insidious onset (HP:0003587) | 1.34274578 |
| 192 | Termporal pattern (HP:0011008) | 1.34274578 |
| 193 | Cerebral ischemia (HP:0002637) | 1.33925714 |
| 194 | Lower limb amyotrophy (HP:0007210) | 1.33762757 |
| 195 | Recurrent abscess formation (HP:0002722) | 1.32258985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.27230591 |
| 2 | MST4 | 5.21442035 |
| 3 | MYLK | 3.77213418 |
| 4 | PRPF4B | 3.45709950 |
| 5 | NEK1 | 3.44059778 |
| 6 | PAK6 | 3.25186605 |
| 7 | TEC | 3.15845745 |
| 8 | BTK | 3.09468170 |
| 9 | EPHA3 | 3.02241975 |
| 10 | TAOK2 | 3.00728980 |
| 11 | INSRR | 2.87886179 |
| 12 | EIF2AK1 | 2.86934718 |
| 13 | PHKG1 | 2.77453918 |
| 14 | PHKG2 | 2.77453918 |
| 15 | PTK2B | 2.72711327 |
| 16 | PINK1 | 2.63797408 |
| 17 | RIPK1 | 2.53136243 |
| 18 | DYRK1A | 2.42271783 |
| 19 | SYK | 2.34162201 |
| 20 | GRK5 | 2.26725804 |
| 21 | CSF1R | 2.22418857 |
| 22 | ZAP70 | 2.19991530 |
| 23 | CDK8 | 2.15837253 |
| 24 | PIK3CG | 2.12747913 |
| 25 | MAP3K13 | 2.10305276 |
| 26 | ILK | 2.01671110 |
| 27 | NME1 | 1.97282376 |
| 28 | MINK1 | 1.95017244 |
| 29 | GRK6 | 1.94136871 |
| 30 | BMPR2 | 1.93666747 |
| 31 | TNK2 | 1.91785921 |
| 32 | FGR | 1.79426659 |
| 33 | MAP3K7 | 1.79324473 |
| 34 | TNIK | 1.78037174 |
| 35 | MARK1 | 1.74750623 |
| 36 | STK38 | 1.73669642 |
| 37 | STK3 | 1.65689789 |
| 38 | EPHA4 | 1.63926407 |
| 39 | RPS6KB2 | 1.60103630 |
| 40 | AKT3 | 1.58337312 |
| 41 | ICK | 1.57575529 |
| 42 | CAMK1D | 1.56603687 |
| 43 | HCK | 1.52883910 |
| 44 | CAMK2D | 1.42135682 |
| 45 | MAP3K4 | 1.40235327 |
| 46 | CLK1 | 1.38155110 |
| 47 | CASK | 1.37517450 |
| 48 | BLK | 1.37471533 |
| 49 | MAPKAPK3 | 1.35870824 |
| 50 | SGK223 | 1.27591491 |
| 51 | SGK494 | 1.27591491 |
| 52 | ADRBK2 | 1.26679845 |
| 53 | PLK2 | 1.24586302 |
| 54 | MATK | 1.23242423 |
| 55 | PRKAA1 | 1.22085016 |
| 56 | PAK1 | 1.20802515 |
| 57 | LYN | 1.19269202 |
| 58 | MAP3K9 | 1.18644423 |
| 59 | MAP2K3 | 1.14814073 |
| 60 | STK24 | 1.13555741 |
| 61 | IKBKB | 1.12239318 |
| 62 | PKN2 | 1.11603930 |
| 63 | ACVR1B | 1.11224147 |
| 64 | DAPK3 | 1.11079412 |
| 65 | BRD4 | 1.07815843 |
| 66 | CAMK1G | 1.02332431 |
| 67 | CAMK1 | 1.00396532 |
| 68 | PNCK | 1.00011034 |
| 69 | PAK3 | 0.97088138 |
| 70 | TXK | 0.95833563 |
| 71 | ITK | 0.94085473 |
| 72 | CDK9 | 0.93178951 |
| 73 | LMTK2 | 0.92352252 |
| 74 | PRKG1 | 0.90742240 |
| 75 | ERBB3 | 0.90432511 |
| 76 | PIM2 | 0.90335786 |
| 77 | MAP3K5 | 0.88632471 |
| 78 | IRAK1 | 0.88621445 |
| 79 | CSK | 0.88485733 |
| 80 | FES | 0.87377320 |
| 81 | SIK3 | 0.84855523 |
| 82 | CDK14 | 0.84392440 |
| 83 | PKN1 | 0.83669292 |
| 84 | ADRBK1 | 0.83052891 |
| 85 | ERBB2 | 0.82672519 |
| 86 | BMX | 0.82198140 |
| 87 | PRKCG | 0.82041753 |
| 88 | GRK1 | 0.82025245 |
| 89 | TRIM28 | 0.81625372 |
| 90 | ROCK2 | 0.80997982 |
| 91 | MARK3 | 0.80372865 |
| 92 | CDK15 | 0.77870351 |
| 93 | NEK6 | 0.76251299 |
| 94 | CDK3 | 0.75529982 |
| 95 | PDK1 | 0.74053115 |
| 96 | TLK1 | 0.73593539 |
| 97 | RET | 0.73494281 |
| 98 | CDK18 | 0.73330486 |
| 99 | CDC42BPA | 0.71318141 |
| 100 | SGK2 | 0.71163073 |
| 101 | MAPK10 | 0.70998853 |
| 102 | FER | 0.70698265 |
| 103 | BRAF | 0.70282224 |
| 104 | PRKCE | 0.70222995 |
| 105 | CAMK2A | 0.69424230 |
| 106 | WNK3 | 0.69180248 |
| 107 | CDK5 | 0.69147067 |
| 108 | PRKD1 | 0.68564624 |
| 109 | FLT3 | 0.67574466 |
| 110 | PRKCA | 0.66463145 |
| 111 | CDK11A | 0.66244175 |
| 112 | YES1 | 0.66169376 |
| 113 | ARAF | 0.65250199 |
| 114 | NUAK1 | 0.65096417 |
| 115 | EPHB2 | 0.63801132 |
| 116 | NTRK2 | 0.63751465 |
| 117 | RPS6KA3 | 0.62498230 |
| 118 | PRKACA | 0.62038464 |
| 119 | PLK3 | 0.61941773 |
| 120 | DAPK2 | 0.60382934 |
| 121 | PDPK1 | 0.60326907 |
| 122 | GSK3B | 0.59115136 |
| 123 | PRKCZ | 0.58664598 |
| 124 | SGK3 | 0.58483661 |
| 125 | MAPK12 | 0.57396474 |
| 126 | PDGFRB | 0.57362712 |
| 127 | MAP3K3 | 0.56943873 |
| 128 | BMPR1B | 0.56665838 |
| 129 | DYRK1B | 0.55436173 |
| 130 | RPS6KA5 | 0.55138241 |
| 131 | CAMK4 | 0.54529258 |
| 132 | TAOK3 | 0.54009624 |
| 133 | LCK | 0.53478970 |
| 134 | PRKG2 | 0.52671511 |
| 135 | HIPK2 | 0.52454347 |
| 136 | TAOK1 | 0.52068036 |
| 137 | PRKCB | 0.51547665 |
| 138 | PRKACB | 0.50870685 |
| 139 | STK4 | 0.49961587 |
| 140 | MAP2K1 | 0.49888780 |
| 141 | MAPK1 | 0.48860957 |
| 142 | EPHB1 | 0.48767496 |
| 143 | SGK1 | 0.47698049 |
| 144 | MAP3K12 | 0.46301762 |
| 145 | FGFR1 | 0.45896112 |
| 146 | RPS6KB1 | 0.45767371 |
| 147 | KSR1 | 0.44979439 |
| 148 | TESK2 | 0.44851701 |
| 149 | MAPK9 | 0.44423420 |
| 150 | FYN | 0.44149111 |
| 151 | MAPK14 | 0.44139032 |
| 152 | JAK2 | 0.43255651 |
| 153 | MAPK13 | 0.41994085 |
| 154 | PRKACG | 0.41684057 |
| 155 | DDR2 | 0.41266885 |
| 156 | DAPK1 | 0.40965102 |
| 157 | MARK2 | 0.40122068 |
| 158 | MAPK8 | 0.40064750 |
| 159 | MAP4K1 | 0.39846523 |
| 160 | AKT1 | 0.39226046 |
| 161 | PRKD2 | 0.38519200 |
| 162 | JAK1 | 0.37956787 |
| 163 | CAMKK2 | 0.37577596 |
| 164 | CAMK2B | 0.37342111 |
| 165 | IRAK2 | 0.37108618 |
| 166 | NTRK3 | 0.36413820 |
| 167 | JAK3 | 0.34686376 |
| 168 | PRKCD | 0.34040908 |
| 169 | PRKCQ | 0.32076349 |
| 170 | NLK | 0.29794488 |
| 171 | IRAK3 | 0.29234813 |
| 172 | PIM1 | 0.27211984 |
| 173 | ROCK1 | 0.26983382 |
| 174 | IRAK4 | 0.26531501 |
| 175 | IGF1R | 0.26443294 |
| 176 | SRC | 0.25997387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.60895612 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 5.17799880 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 4.02450505 |
| 4 | Circadian rhythm_Homo sapiens_hsa04710 | 3.72650126 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.65142777 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.45167709 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 3.31391923 |
| 8 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.28132727 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.22219351 |
| 10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.97253608 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.68435400 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51652932 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.49787686 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.39533332 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.29411346 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25057475 |
| 17 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.09681981 |
| 18 | Phototransduction_Homo sapiens_hsa04744 | 2.07186095 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 2.05567624 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03507668 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01471551 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.99688160 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.94305012 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.93230229 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93138619 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.92820606 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.87458410 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.85817064 |
| 29 | Mineral absorption_Homo sapiens_hsa04978 | 1.79272719 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.77166688 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74536506 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66930614 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.66157807 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.65528769 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54010603 |
| 36 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.53946782 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46165181 |
| 38 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43844245 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41189518 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40057591 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.37888012 |
| 42 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.37854431 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.36905062 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.34575139 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.33672789 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.32660485 |
| 47 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29677138 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26032071 |
| 49 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25739272 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22363171 |
| 51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.19957808 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16954112 |
| 53 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16860535 |
| 54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15538412 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15479757 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14370626 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14197404 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12461566 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.06596939 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03256226 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 1.01179899 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00804273 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.99794505 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 0.97793423 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95603549 |
| 66 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93474021 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92317542 |
| 68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91136039 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91074724 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90393828 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.90344142 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88913992 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.86378884 |
| 74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.86306429 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.86230653 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83486769 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83426475 |
| 78 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82762076 |
| 79 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.81509221 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78938387 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78475933 |
| 82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.74310418 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73237412 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72983851 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.70726709 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70504497 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69559501 |
| 88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67911959 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67098722 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66645236 |
| 91 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65795195 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65273635 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63984689 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59175192 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59147254 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57865760 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57848624 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55537062 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54371164 |
| 100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53221794 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.52936372 |
| 102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52498352 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52399916 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52394819 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52286688 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51640304 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.51386919 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49173250 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49074196 |
| 110 | Mismatch repair_Homo sapiens_hsa03430 | 0.48699390 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.48439912 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.47516973 |
| 113 | ABC transporters_Homo sapiens_hsa02010 | 0.46215209 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.46011461 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44845845 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43724268 |
| 117 | Glioma_Homo sapiens_hsa05214 | 0.41483081 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40042272 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40037662 |
| 120 | Bile secretion_Homo sapiens_hsa04976 | 0.39134643 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38718003 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37704411 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.36820312 |
| 124 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36810649 |
| 125 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36741302 |
| 126 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36509691 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36376833 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.36134681 |
| 129 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36078613 |
| 130 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35611319 |
| 131 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35110144 |
| 132 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31235203 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.29288892 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28120879 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27956014 |
| 136 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.27654969 |
| 137 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26762106 |
| 138 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.26000072 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.25084782 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.24329373 |
| 141 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24063978 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.23388925 |
| 143 | Alcoholism_Homo sapiens_hsa05034 | 0.22512838 |
| 144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.19320293 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19153799 |
| 146 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18209079 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16930148 |
| 148 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.15798786 |
| 149 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.15061773 |
| 150 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.14040251 |
| 151 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13717460 |
| 152 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11864145 |
| 153 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.11587965 |
| 154 | RNA degradation_Homo sapiens_hsa03018 | 0.11454791 |
| 155 | Lysine degradation_Homo sapiens_hsa00310 | 0.10747826 |
| 156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.10139284 |
| 157 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08598735 |
| 158 | Axon guidance_Homo sapiens_hsa04360 | 0.08273888 |
| 159 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07743479 |
| 160 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06669591 |
| 161 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.06421677 |
| 162 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04790915 |
| 163 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.04306566 |
| 164 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.03780537 |

